Skip to main content

TM

Stock

TM

Stock
Consumer Discretionary
Auto Manufacturers

Performance overview

TM Price
Price Chart

Forward-looking statistics

Beta
0.71
Risk
28.56%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Toyota Motor Corporation is a Japanese multinational automotive manufacturer headquartered in Toyota City, Aichi, Japan. It was founded by Kiichiro Toyoda and incorporated on August 28, 1937. Toyota is one of the largest automobile manufacturers in the world, producing about 10 million vehicles per year.

Company info

SectorConsumer Discretionary
IndustryAuto Manufacturers
Employees378K
Market cap$277.9B

Fundamentals

Enterprise value$228.5B
Revenue$332.6B
Revenue per employee—
Profit margin9.92%
Debt to equity105.19

Security info

ExchangeNyse American
Type of shareADR
Earnings per share (EPS)$25.06
Dividend per share$3.53
Revenue per share$2,265.46
Avg trading volume (30 day)$74M
Avg trading volume (10 day)$77M
Put-call ratio—

Macro factor sensitivity

Growth+3.5
Credit-1.5
Liquidity-1.1
Inflation+1.6
Commodities+1.3
Interest Rates-0.7

Valuation

Dividend yield2.10%
PEG Ratio10.77
Price to sales0.00
P/E Ratio10.77
Enterprise Value to Revenue0.69
Price to book0.06

Upcoming events

Next earnings dayMay 10, 2023
Next dividend day—
Ex. dividend dayMarch 31, 2025

News

DOJ ends probe into T-Mobile's $4.4 billion merger 2 days after the company committed to end DEI policies

T-Mobile told the FCC this week that it was ending its DEI policies. The company has been awaiting FCC approval for two deals.

Business Insider (July 11, 2025)
JBT Marel (JBTM) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, JBT Marel Corporation (JBTM) is looking like an interesting pick, as it just reached a key level of support. JBTM's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Zacks Investment Research (July 11, 2025)
RYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study Data

Rhythm Pharmaceuticals jumps 36.6% after its oral drug bivamelagon shows strong BMI and hunger reductions in a phase II study in acquired hypothalamic obesity.

Zacks Investment Research (July 10, 2025)
Bitcoin Depot Surges 250.6% YTD: Is it Too Late to Buy BTM Stock?

BTM skyrockets 250.6% YTD on crypto demand and expansion, but does it have more upside left? Let's find out.

Zacks Investment Research (July 10, 2025)
Here's Why T-Mobile (TMUS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research (July 10, 2025)
New Strong Buy Stocks for July 10th

ASTH, LGCY, STM, BAYRY and KD have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2025.

Zacks Investment Research (July 10, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free